Axe Compute Share Holder Equity 2012-2025 | AGPU
Axe Compute share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
|
Axe Compute Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $8 |
| 2022 | $22 |
| 2021 | $40 |
| 2020 | $3 |
| 2019 | $11 |
| 2018 | $0 |
| 2017 | $3 |
| 2016 | $1 |
| 2015 | $4 |
| 2014 | $-6 |
| 2013 | $-3 |
| 2012 | $-3 |
| 2011 | $-3 |
|
Axe Compute Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-77 |
| 2025-06-30 | $-2 |
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $2 |
| 2024-06-30 | $4 |
| 2024-03-31 | $4 |
| 2023-12-31 | $8 |
| 2023-09-30 | $12 |
| 2023-06-30 | $15 |
| 2023-03-31 | $19 |
| 2022-12-31 | $22 |
| 2022-09-30 | $30 |
| 2022-06-30 | $34 |
| 2022-03-31 | $37 |
| 2021-12-31 | $40 |
| 2021-09-30 | $48 |
| 2021-06-30 | $53 |
| 2021-03-31 | $36 |
| 2020-12-31 | $3 |
| 2020-09-30 | $12 |
| 2020-06-30 | $12 |
| 2020-03-31 | $10 |
| 2019-12-31 | $11 |
| 2019-09-30 | $21 |
| 2019-06-30 | $22 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $3 |
| 2018-06-30 | $3 |
| 2018-03-31 | $5 |
| 2017-12-31 | $3 |
| 2017-09-30 | $2 |
| 2017-06-30 | $3 |
| 2017-03-31 | $4 |
| 2016-12-31 | $1 |
| 2016-09-30 | $0 |
| 2016-06-30 | $1 |
| 2016-03-31 | $3 |
| 2015-12-31 | $4 |
| 2015-09-30 | $6 |
| 2015-06-30 | $-6 |
| 2015-03-31 | $-6 |
| 2014-12-31 | $-6 |
| 2014-09-30 | $-4 |
| 2014-06-30 | $-3 |
| 2014-03-31 | $-2 |
| 2013-12-31 | $-3 |
| 2013-09-30 | $-1 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-3 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-2 |
| 2012-06-30 | $-2 |
| 2012-03-31 | $-3 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-2 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.008B | $0.002B |
| Axe Compute Inc. is engaged in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients. Axe Compute Inc., formerly known as Predictive Oncology Inc., is based in PITTSBURGH, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $114.495B | 24.87 |
| Cardinal Health (CAH) | United States | $51.955B | 22.98 |
| Becton Dickinson (BDX) | United States | $50.083B | 12.65 |
| West Pharmaceutical Services (WST) | United States | $18.021B | 34.36 |
| Cooper (COO) | United States | $16.264B | 20.09 |
| Align Technology (ALGN) | United States | $13.401B | 22.75 |
| Henry Schein (HSIC) | United States | $9.205B | 16.22 |
| Merit Medical Systems (MMSI) | United States | $4.842B | 23.81 |
| DENTSPLY SIRONA (XRAY) | United States | $2.583B | 8.20 |
| CONMED (CNMD) | United States | $1.294B | 9.07 |
| STAAR Surgical (STAA) | United States | $0.801B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.127B | 15.07 |
| Lifevantage (LFVN) | United States | $0.064B | 6.62 |